Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Pulmonary Hypertension

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 145 articles:
HTML format



Single Articles


    March 2024
  1. YOGESWARAN A, Gall H, Funderich M, Wilkins MR, et al
    Comparison of contemporary risk scores in all groups of pulmonary hypertension - a PVRI GoDeep meta-registry analysis.
    Chest. 2024 Mar 18:S0012-3692(24)00309-X. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  2. O'MEARA K, Stone G, Buch E, Brownstein A, et al
    Atrial Arrhythmias in Patients with Pulmonary Hypertension.
    Chest. 2024 Mar 5:S0012-3692(24)00291-5. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  3. PROVENCHER S, Mai V, Bonnet S
    Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities.
    Chest. 2024;165:682-691.
    PubMed     Abstract available


  4. OROZCO-LEVI M, de Jesus Perez V
    Precision Solutions: A Strategy to Improve Medical Care for Patients With Pulmonary Hypertension in Latin America.
    Chest. 2024;165:669-672.
    PubMed    


  5. SAHAY S
    Counterpoint: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? No.
    Chest. 2024;165:494-496.
    PubMed    


  6. WEATHERALD J, Sitbon O
    POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
    Chest. 2024;165:492-494.
    PubMed    


    February 2024
  7. BALASUBRAMANIAN A, Larive B, Horn EM, DuBrock HM, et al
    Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.
    Chest. 2024 Feb 12:S0012-3692(24)00155-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


  8. FAUVEL C, White RJ, Vanderpool RR, Badagliacca R, et al
    Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
    Chest. 2024;165:431-436.
    PubMed    


  9. MOORE J, Remy J, Altschul E, Chusid J, et al
    Thoracic Applications of Spectral CT Scan.
    Chest. 2024;165:417-430.
    PubMed     Abstract available


    January 2024
  10. FRANTZ RP, Swift AJ
    Advancing Risk Stratification in Pulmonary Arterial Hypertension Through Cardiac MRI: The Need for Collaboration and Standardization.
    Chest. 2024;165:12-13.
    PubMed    


  11. CELANT LR, Wessels JN, Marcus JT, Meijboom LJ, et al
    Toward the Implementation of Optimal Cardiac Magnetic Resonance Risk Stratification in Pulmonary Arterial Hypertension.
    Chest. 2024;165:181-191.
    PubMed     Abstract available


    December 2023
  12. LUI JK, Cozzolino M, Winburn M, Trojanowski MA, et al
    Role of Left Ventricular Dysfunction in Systemic Sclerosis-related Pulmonary Hypertension.
    Chest. 2023 Dec 19:S0012-3692(23)05932-9. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  13. FAUVEL C, Liu Y, Correa-Jaque P, Kanwar MK, et al
    Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.
    Chest. 2023;164:1518-1530.
    PubMed     Abstract available


    October 2023
  14. SELF A, Afshar K, Kafi A, Yung G, et al
    An Unexpected Cause of Lung Disease Identified After Lung Transplantation.
    Chest. 2023;164:e111-e115.
    PubMed     Abstract available


    August 2023
  15. MOINZADEH P, Bonella F, Oberste M, Weliwitage J, et al
    Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival - a large cohort study of the German network for systemic sclerosis.
    Chest. 2023 Aug 13:S0012-3692(23)05274-1. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  16. KULARATNE M, Eyries M, Savale L, Humbert M, et al
    Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants.
    Chest. 2023;164:e23-e26.
    PubMed     Abstract available


    July 2023
  17. CARBONE RG, Monselise A, Puppo F
    Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease: Is All Clear?
    Chest. 2023;164:e21.
    PubMed    


  18. DUBROCK HM
    Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
    Chest. 2023;164:206-214.
    PubMed     Abstract available


    June 2023
  19. SULLIVAN RT, Austin ED
    Developing a Broader Understanding of Pediatric PAH Worldwide.
    Chest. 2023;163:1353-1355.
    PubMed    


  20. QIAN Y, Quan R, Chen X, Gu Q, et al
    Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Chest. 2023;163:1531-1542.
    PubMed     Abstract available


    May 2023
  21. KOLAITIS NA
    Lung Transplantation for Pulmonary Arterial Hypertension.
    Chest. 2023 May 5:S0012-3692(23)00649-9. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  22. SCARPATO BM, McDonald J, Bayrak-Toydemir P, Elliott CG, et al
    The Shunt of It.
    Chest. 2023;163:e201-e205.
    PubMed     Abstract available


  23. THENAPPAN T, Brittain EL
    Right Ventricular Imaging for Predicting Risk in Pulmonary Arterial Hypertension: The Elephant in the Room.
    Chest. 2023;163:1013-1015.
    PubMed    


  24. EL-KERSH K, Zhao C, Elliott G, Farber HW, et al
    Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension.
    Chest. 2023;163:1232-1244.
    PubMed     Abstract available


    April 2023
  25. FORBES LM, Bull TM, Lahm T, Make BJ, et al
    Exercise Testing in the Risk Assessment of Pulmonary Hypertension.
    Chest. 2023 Apr 13:S0012-3692(23)00509-3. doi: 10.1016/j.chest.2023.
    PubMed    


    March 2023
  26. YANG J, Madani MM, Mahmud E, Kim NH, et al
    " Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension".
    Chest. 2023 Mar 27:S0012-3692(23)00457-9. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  27. AL-QADI MO, Holbrook J, Ford HJ, Ceppe A, et al
    Prognostic Value of Respiratory Variation in Right Atrial Pressure in Patients with Precapillary Pulmonary Hypertension.
    Chest. 2023 Mar 27:S0012-3692(23)00458-0. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


  28. KITHAS AC, Ramani GV, Cassady SJ
    A Rapidly Evacuated Pericardial Effusion in the Setting of Chronic Pulmonary Hypertension.
    Chest. 2023;163:e137-e139.
    PubMed    


    February 2023
  29. HOWARD LS, Rosenkranz S, Frantz RP, Hemnes AR, et al
    Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).
    Chest. 2023;163:407-418.
    PubMed     Abstract available


    January 2023
  30. BARCO S, Mavromanoli AC, Kreitner KF, Bunck AC, et al
    Pre-existing chronic thromboembolic pulmonary hypertension in acute pulmonary embolism.
    Chest. 2023 Jan 5:S0012-3692(23)00013-2. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  31. ALOTAIBI M, Shao J, Pauciulo MW, Nichols WC, et al
    Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity.
    Chest. 2023;163:204-215.
    PubMed     Abstract available


    December 2022
  32. WU S, Hoang HB, Yang JZ, Papamatheakis DG, et al
    Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension.
    Chest. 2022;162:1360-1372.
    PubMed     Abstract available


  33. LACHANT D, Kennedy E, Derenze B, Light A, et al
    Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension.
    Chest. 2022;162:1340-1348.
    PubMed     Abstract available


    October 2022
  34. MARON BA, Kleiner DE, Arons E, Wertheim BM, et al
    Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy with Pulmonary Hypertension.
    Chest. 2022 Oct 12. pii: S0012-3692(22)03912-5. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


    September 2022
  35. NATHAN SD, Deng C, King CS, DuBrock HM, et al
    Inhaled Treprostinil Dose in Pulmonary Hypertension Associated with Interstitial Lung Disease and Its Effects on Clinical Outcomes.
    Chest. 2022 Sep 14. pii: S0012-3692(22)03725-4. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  36. CHANNICK R, Robert Naeije
    A Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Yes, But How?
    Chest. 2022;162:511-513.
    PubMed    


  37. SHELBURNE NJ, Frantz RP
    The Oracle of the Auricle?: Optimizing Serial Risk Stratification of Patients With Pulmonary Arterial Hypertension.
    Chest. 2022;162:509-510.
    PubMed    


  38. SHAH T, Manthena P, Patel C, Chuah A, et al
    Prognostic Value of Echocardiographic Variables Prior to and Following Initiation of Parenteral Prostacyclin Therapy: An Observational Study.
    Chest. 2022;162:669-683.
    PubMed     Abstract available


    August 2022
  39. YARLAS A, Mathai SC, Nathan SD, DuBrock HM, et al
    Considerations when Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients with Pulmonary Hypertension: A Narrative Review.
    Chest. 2022 Aug 20. pii: S0012-3692(22)03649.
    PubMed     Abstract available


  40. MCCARTHY BE, McClelland RL, Appleby DH, Moutchia JS, et al
    BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis.
    Chest. 2022;162:436-447.
    PubMed     Abstract available


    July 2022
  41. MORRIS TA, Fernandes TM, Channick R
    How we do it: evaluation of dyspnea and exercise intolerance after acute pulmonary embolism.
    Chest. 2022 Jul 2. pii: S0012-3692(22)01215-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


    June 2022
  42. SCHWIENING M, Swietlik EM, Pandya D, Burling K, et al
    Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.
    Chest. 2022;161:1651-1656.
    PubMed    


    May 2022
  43. HADDAD F, Contrepois K, Amsallem M, Denault AY, et al
    The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension.
    Chest. 2022;161:1347-1359.
    PubMed     Abstract available


    April 2022
  44. MA X, Yu D, Jie B, Li LL, et al
    Endovascular Treatment of Central Pulmonary Arterial Pseudoaneurysms in the Context of Silicosis Combined with Pulmonary Tuberculosis.
    Chest. 2022 Apr 28. pii: S0012-3692(22)00880-7. doi: 10.1016/j.chest.2022.
    PubMed    


  45. KHIRFAN G, Melillo CA, Al Abdi S, Lane JE, et al
    Impact of Esophageal Pressure Measurement on Pulmonary Hypertension Diagnosis in Obese Patients.
    Chest. 2022 Apr 8. pii: S0012-3692(22)00592-X. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  46. CONDON DF, Agarwal S, Chakraborty A, Auer N, et al
    Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension.
    Chest. 2022;161:1060-1072.
    PubMed     Abstract available


  47. VANDERPOOL RR, Hunter KS, Insel M, Garcia JGN, et al
    The Right Ventricular-Pulmonary Arterial Coupling and Diastolic Function Response to Therapy in Pulmonary Arterial Hypertension.
    Chest. 2022;161:1048-1059.
    PubMed     Abstract available


    February 2022
  48. RAHAGHI FF, Kolaitis NA, Adegunsoye A, de Andrade J, et al
    Screening Strategies for Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Multidisciplinary Delphi Study.
    Chest. 2022 Feb 14. pii: S0012-3692(22)00262-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  49. JOHNSON SW, Maron BA
    COUNTERPOINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? No.
    Chest. 2022;161:313-315.
    PubMed    


  50. KOVACS G
    POINT: Did the World Symposium on Pulmonary Hypertension Get It Right in Redefining Abnormal Pulmonary Arterial Pressure? Yes.
    Chest. 2022;161:311-312.
    PubMed    


  51. GENTY T, Wirth C, Humbert M, Fadel E, et al
    Pulmonary Endarterectomy in Patients With Myeloproliferative Neoplasms.
    Chest. 2022;161:552-556.
    PubMed    


    January 2022
  52. KOVACS G, Avian A, Bachmaier G, Troester N, et al
    Severe pulmonary hypertension in COPD - impact on survival and diagnostic approach.
    Chest. 2022 Jan 26. pii: S0012-3692(22)00192-1. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available


  53. LANE T, Hountras P
    A 65-Year-Old Man With Weight Loss, Peripheral Neuropathy, and Lower Extremity Swelling.
    Chest. 2022;161:e29-e34.
    PubMed     Abstract available


  54. MURRAY E, Taylor J, Hountras P
    A Case of High-Output Heart Failure.
    Chest. 2022;161:e23-e28.
    PubMed     Abstract available


  55. LECHARTIER B, Berrebeh N, Huertas A, Humbert M, et al
    Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for Therapy.
    Chest. 2022;161:219-231.
    PubMed     Abstract available


  56. ALQALYOOBI S, Liao SY, Qureshi W, Obi ON, et al
    National Temporal Trends in Hospitalization and Inpatient Mortality in Patients With Pulmonary Sarcoidosis in the United States Between 2007 and 2018.
    Chest. 2022;161:152-168.
    PubMed     Abstract available


    December 2021
  57. LEE MH, Doran J, Bang TJ, Hohsfield R, et al
    Pulmonary Arterial Hypertension and Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Novel Association?
    Chest. 2021;160:2260-2265.
    PubMed    


  58. RAHAGHI FN, Nardelli P, Harder E, Singh I, et al
    Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT Imaging.
    Chest. 2021;160:2220-2231.
    PubMed     Abstract available


    November 2021
  59. ZHENG Z, Chen R, Liu H, Lu J, et al
    The Impact of Clinical Treatment Plan of the New Definition of Precapillary Pulmonary Hypertension.
    Chest. 2021;160:e540-e541.
    PubMed    


  60. LANG IM
    Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Pulmonary Endarterectomy First!
    Chest. 2021;160:1599-1601.
    PubMed    


  61. GOEL K, Maleki-Fischbach M, George MP, Kim D, et al
    A 56-Year-Old Man With Emphysema, Rash, and Arthralgia.
    Chest. 2021;160:e513-e518.
    PubMed     Abstract available


  62. FAKILI F, Duzen IV, Kaplan M, Bayram NG, et al
    A 24-Year-Old Woman With Dyspnea, Chest Pain, and Dry Cough.
    Chest. 2021;160:e503-e506.
    PubMed     Abstract available


  63. GOEL K, Hon SM, Farber HW, George MP, et al
    Pulmonary Arterial Hypertension: What Rare Diseases Tell Us About Disparities in Disease Registries, Clinical Trials, and Treatment Algorithms.
    Chest. 2021;160:1981-1983.
    PubMed    


  64. KERR KM, Elliott CG, Chin K, Benza RL, et al
    Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up.
    Chest. 2021;160:1822-1831.
    PubMed     Abstract available


    October 2021
  65. BOGAARD HJ, Aman J
    Neutrophil Elastase: Finding Its Way From Mechanism, via Biomarker to Treatment Target in Pulmonary Hypertension?
    Chest. 2021;160:1177-1178.
    PubMed    


  66. DUVVURI PD, Bhardwaj C, Wattanakit K
    A 50-Year-Old Woman With Shortness of Breath.
    Chest. 2021;160:e365-e368.
    PubMed    


  67. SWEATT AJ, Miyagawa K, Rhodes CJ, Taylor S, et al
    Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency.
    Chest. 2021;160:1442-1458.
    PubMed     Abstract available


  68. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    PubMed     Abstract available


    September 2021
  69. MARRA AM, Sherman AE, Salzano A, Guazzi M, et al
    Right Heart-Pulmonary Circulation Unit Involvement in Left-sided Heart Failure: Diagnostic, Prognostic and Therapeutic Implications. From the Forgotten Chamber to the Chamber of Secrets.
    Chest. 2021 Sep 27. pii: S0012-3692(21)04062-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  70. GALLINI JW, Benkeser D, Cui X, Shah AJ, et al
    Pulmonary hypertension: a new vascular complication of diabetes?
    Chest. 2021 Sep 16. pii: S0012-3692(21)03863-0. doi: 10.1016/j.chest.2021.
    PubMed    


  71. QURESHI R, Vayntrub Y, Aswad B, Choudhary G, et al
    Dyspnea, Elevated Jugular Venous Pulse, and Lower Extremity Edema in the Setting of Interstitial Lung Disease in a Patient Who Has Undergone Liver and Kidney Transplantation.
    Chest. 2021;160:e295-e298.
    PubMed     Abstract available


  72. HEMNES AR, Silverman-Lloyd LG, Huang S, MacKinnon G, et al
    A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension.
    Chest. 2021;160:1042-1052.
    PubMed     Abstract available


    August 2021
  73. INAMPUDI C, Silverman D, Simon MA, Leary PJ, et al
    Pulmonary Hypertension in the Context of Heart Failure with Preserved Ejection Fraction.
    Chest. 2021 Aug 12. pii: S0012-3692(21)03666-7. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  74. BAUGHMAN RP, Shlobin OA, Gupta R, Engel PJ, et al
    Riociguat for Sarcoidosis Associated Pulmonary Hypertension: Results of a One Year Double Blind, Placebo Controlled Trial.
    Chest. 2021 Aug 4. pii: S0012-3692(21)03613-8. doi: 10.1016/j.chest.2021.07.2162
    PubMed     Abstract available


  75. TATAH J, Keen JL, Prisco SZ, Pritzker M, et al
    Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease.
    Chest. 2021 Aug 2. pii: S0012-3692(21)03610-2. doi: 10.1016/j.chest.2021.07.2159
    PubMed    


  76. KLINGER JR
    Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?
    Chest. 2021;160:409-410.
    PubMed    


  77. ROGERS E, Moffet EW, Allen N, Rivera-Zengotita M, et al
    A 60-Year-Old Man With Dyspnea, Proximal Muscle Weakness, and Pulmonary Arterial Hypertension.
    Chest. 2021;160:e225-e231.
    PubMed     Abstract available


    July 2021
  78. MONTANE BE, Fiore AM, Reznicek EC, Jain V, et al
    Optimal Tricuspid Regurgitation Velocity to Screen for Pulmonary Hypertension in Tertiary Referral Centers.
    Chest. 2021 Jul 1. pii: S0012-3692(21)01276-9. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  79. GRIFFITHS M, Yang J, Simpson CE, Vaidya D, et al
    ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical Worsening.
    Chest. 2021;160:297-306.
    PubMed     Abstract available


  80. GAINE S, Sitbon O, Channick RN, Chin KM, et al
    Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON Study.
    Chest. 2021;160:277-286.
    PubMed     Abstract available


    June 2021
  81. TAKAHASHI T, Terada Y, Pasque MK, Liu J, et al
    Clinical features and outcomes of combined pulmonary fibrosis and emphysema after lung transplantation.
    Chest. 2021 Jun 26. pii: S0012-3692(21)01264-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  82. KILICKIRAN AVCI B, Ozden Tok O, Kalangos A, Alkan Bozkaya T, et al
    A 19-Year-Old Pregnant Woman With Pulmonary Hypertension With Progressive Dyspnea.
    Chest. 2021;159:e371-e375.
    PubMed     Abstract available


    May 2021
  83. BRITTAIN EL, Callahan SJ
    Finding Needles in a Haystack: Progress Toward Identifying Pulmonary Arterial Hypertension With the Use of Administrative Data.
    Chest. 2021;159:1713-1714.
    PubMed    


  84. GILLMEYER KR, Nunez ER, Rinne ST, Qian SX, et al
    Development and Validation of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data.
    Chest. 2021;159:1986-1994.
    PubMed     Abstract available


    April 2021
  85. TRAMMELL AW, Hart CM
    Identifying New Targets for Treatment of Pulmonary Hypertension.
    Chest. 2021;159:1326-1327.
    PubMed    


  86. OPPEGARD LJ, Hedstrom G, Levene J, Desai S, et al
    A 44-Year-Old Man Presenting With Massive Hemoptysis and Dyspnea.
    Chest. 2021;159:e237-e241.
    PubMed     Abstract available


  87. TATAH JH, Weir EK, Prins KW, Thenappan T, et al
    A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.
    Chest. 2021;159:e193-e196.
    PubMed     Abstract available


  88. VAN DER BRUGGEN CE, Handoko ML, Bogaard HJ, Marcus JT, et al
    The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension.
    Chest. 2021;159:1575-1585.
    PubMed     Abstract available


    March 2021
  89. CERTAIN MC, Chaumais MC, Jais X, Savale L, et al
    Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
    Chest. 2021;159:1197-1207.
    PubMed     Abstract available


    February 2021
  90. VIZZA CD, Hoeper MM, Huscher D, Pittrow D, et al
    Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA.
    Chest. 2021 Feb 10. pii: S0012-3692(21)00272-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available


  91. BRACK T
    Into Thin Air: A Step Forward to Counsel Patients With Pulmonary Hypertension Travelling to High Altitude.
    Chest. 2021;159:484-485.
    PubMed    


  92. ULRICH S, Mathai SC
    Performance Under Pressure: The Relevance of Pulmonary Vascular Response to Exercise Challenge in Scleroderma.
    Chest. 2021;159:481-483.
    PubMed    


  93. SYNN AJ, Li W, Hunninghake GM, Washko GR, et al
    Vascular Pruning on CT and Interstitial Lung Abnormalities in the Framingham Heart Study.
    Chest. 2021;159:663-672.
    PubMed     Abstract available


    January 2021
  94. KOVACS G, Zeder K, Rosenstock P, Avian A, et al
    Clinical impact of the new definition of pre-capillary pulmonary hypertension.
    Chest. 2021 Jan 5. pii: S0012-3692(20)35526-4. doi: 10.1016/j.chest.2020.
    PubMed    


  95. ZIREK F, Akova BS, Ozcan G, Fitoz S, et al
    A 2-Year-Old Boy With Hypoxemia, Pulmonary Hypertension, and Digital Clubbing.
    Chest. 2021;159:e45-e48.
    PubMed     Abstract available


  96. FORD HJ, LeVarge B
    The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?
    Chest. 2021;159:14-16.
    PubMed    


  97. BENZA RL, Kanwar MK, Raina A, Scott JV, et al
    Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.
    Chest. 2021;159:337-346.
    PubMed     Abstract available


  98. DUBROCK HM, Cartin-Ceba R, Channick RN, Kawut SM, et al
    Sex Differences in Portopulmonary Hypertension.
    Chest. 2021;159:328-336.
    PubMed     Abstract available


  99. THAYER TE, Levinson RT, Huang S, Assad T, et al
    BMI Is Causally Associated With Pulmonary Artery Pressure But Not Hemodynamic Evidence of Pulmonary Vascular Remodeling.
    Chest. 2021;159:302-310.
    PubMed     Abstract available


    December 2020
  100. WACKER J, Aggoun Y, Terraz S, Golay E, et al
    A 13-Year-Old Male With Diagnosed Idiopathic Pulmonary Hypertension: Is it Really Idiopathic?
    Chest. 2020;158:e295-e298.
    PubMed     Abstract available


  101. GUPTA S, Batt J, Bourbeau J, Chapman KR, et al
    Triaging Access to Critical Care Resources in Patients With Chronic Respiratory Diseases in the Event of a Major COVID-19 Surge: Key Highlights From the Canadian Thoracic Society (CTS) Position Statement.
    Chest. 2020;158:2270-2274.
    PubMed    


  102. KOURI A, Gupta S, Yadollahi A, Ryan CM, et al
    Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic.
    Chest. 2020;158:2502-2510.
    PubMed     Abstract available


    October 2020
  103. LAHM T, Hess E, Baron AE, Maddox TM, et al
    Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension: Insights from the Veterans Affairs CART Database.
    Chest. 2020 Oct 5. pii: S0012-3692(20)34851-0. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    September 2020
  104. CHEREL B, Humbert M, LeBlanc F, Zambello R, et al
    Large granular lymphocyte leukemia and pre-capillary pulmonary hypertension.
    Chest. 2020 Sep 10. pii: S0012-3692(20)34353-1. doi: 10.1016/j.chest.2020.
    PubMed    


  105. SIMON R S, Laura C M, Mona L, Charlotte B, et al
    Effect of normobaric hypoxia on exercise performance in pulmonary hypertension - randomized trial.
    Chest. 2020 Sep 9. pii: S0012-3692(20)34370-1. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    August 2020
  106. BADLAM JB, Badesch DB, Austin ED, Benza RL, et al
    United States Pulmonary Hypertension Scientific Registry (USPHSR): Baseline Characteristics.
    Chest. 2020 Aug 25. pii: S0012-3692(20)34279-3. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    June 2020
  107. HEIDEN GI, Sobral JB, Goncalves Freitas CS, Pereira de Albuquerque AL, et al
    Mechanisms of exercise limitation and prevalence of pulmonary hypertension in pulmonary Langerhans cell histiocytosis.
    Chest. 2020 Jun 29. pii: S0012-3692(20)31823-7. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


    May 2020
  108. KING CS, Shlobin OA
    The Trouble with Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
    Chest. 2020 May 6. pii: S0012-3692(20)30872-2. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  109. MASLONKA M, Miles M
    Pulmonary Hypertension, Eggs, and Bananas.
    Chest. 2020;157:1393-1394.
    PubMed    


    April 2020
  110. MARON BA
    Rebuttal From Dr Maron.
    Chest. 2020;157:769-770.
    PubMed    


  111. FRANTZ RP
    Rebuttal From Dr Frantz.
    Chest. 2020;157:768-769.
    PubMed    


  112. WHITE RJ, Lachant DJ
    Selexipag Use in Clinical Practice: Mind the Gap.
    Chest. 2020;157:761-763.
    PubMed    


  113. TISSOT N, Montani D, Seronde MF, Degano B, et al
    Venoocclusive Disease With Both Hepatic and Pulmonary Involvement.
    Chest. 2020;157:e107-e109.
    PubMed     Abstract available


  114. FRANTZ RP
    COUNTERPOINT: Should the New Definition of PH Be the Clinical Practice Standard? No.
    Chest. 2020;157:766-768.
    PubMed    


  115. MARON BA
    POINT: Should the New Definition of PH Be the Clinical Practice Standard? Yes.
    Chest. 2020;157:764-766.
    PubMed    


  116. HACHULLA E, Launay D, Boucly A, Mouthon L, et al
    Survival Improved in Patients Aged
    Chest. 2020;157:945-954.
    PubMed     Abstract available


  117. MCLAUGHLIN VV, Channick R, De Marco T, Farber HW, et al
    Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents.
    Chest. 2020;157:955-965.
    PubMed     Abstract available


    March 2020
  118. BALASUBRAMANIAN A, Kolb TM, Damico RL, Hassoun PM, et al
    Diffusing Capacity is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
    Chest. 2020 Mar 14. pii: S0012-3692(20)30445-1. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  119. NEWMAN JH
    Pulmonary Hypertension by the Method of Paul Wood.
    Chest. 2020 Mar 5. pii: S0012-3692(20)30428-1. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  120. AGARWALA P, Salzman SH
    Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.
    Chest. 2020;157:603-611.
    PubMed     Abstract available


    February 2020
  121. NATHAN SD, Flaherty KR, Glassberg MK, Raghu G, et al
    A Randomized, double-blind, placebo-controlled study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) at a dose of 30 mcg/kg-IBW/hr (iNO 30) in subjects at risk of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF
    Chest. 2020 Feb 21. pii: S0012-3692(20)30327-5. doi: 10.1016/j.chest.2020.
    PubMed     Abstract available


  122. MCCARRON EP, Sreenivasan S, Monaghan M
    Cardiac Magnetic Resonance Imaging in Pulmonary Hypertension.
    Chest. 2020;157:470.
    PubMed    


  123. ALTSCHUL E, Remy-Jardin M, Sulica R, Raoof S, et al
    Response.
    Chest. 2020;157:471.
    PubMed    


  124. VONK NOORDEGRAAF A, Bogaard HJ
    Restoring the Right Ventricle.
    Chest. 2020;157:251-252.
    PubMed    


  125. GAYEN SK, Abdelrahman AA, Preston IR, Petit RD, et al
    Vitamin C Deficiency-Induced Pulmonary Arterial Hypertension.
    Chest. 2020;157:e21-e23.
    PubMed     Abstract available


  126. D'ALTO M, Badagliacca R, Argiento P, Romeo E, et al
    Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.
    Chest. 2020;157:376-383.
    PubMed     Abstract available


    January 2020
  127. SIMPSON CE, Damico RL, Hassoun PM, Martin LJ, et al
    Noninvasive prognostic biomarkers for left heart failure as predictors of survival in pulmonary arterial hypertension.
    Chest. 2020 Jan 24. pii: S0012-3692(20)30129-X. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  128. CLADELLAS M, Garcia-Ribas C, Ble M, Gomez M, et al
    Impact of preoperative right heart chambers measurement in the evaluation of pulmonary hypertension after aortic valve replacement.
    Chest. 2020 Jan 17. pii: S0012-3692(20)30020-9. doi: 10.1016/j.chest.2019.
    PubMed     Abstract available


  129. GAINE S
    How the Right Heart Is Measuring Up in Pulmonary Hypertension.
    Chest. 2020;157:1-2.
    PubMed    


  130. BAX S, Jacob J, Ahmed R, Bredy C, et al
    Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease.
    Chest. 2020;157:89-98.
    PubMed     Abstract available


    September 2019
  131. ANDERSON JJ, Lau EM, Lavender M, Benza R, et al
    Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
    Chest. 2019 Sep 26. pii: S0012-3692(19)33934.
    PubMed     Abstract available


    July 2019
  132. ROBBINS IM
    Pulmonary Edema After Initiation of Parenteral Prostaglandin Therapy: More Common Than We Think but How Clinically Important Is It?
    Chest. 2019;156:7-8.
    PubMed    


  133. KLINGER JR, Elliott G, Levine DJ, Bossone E, et al
    Response.
    Chest. 2019;156:187-188.
    PubMed    


  134. DURRANI J, Toor A
    Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.
    Chest. 2019;156:187.
    PubMed    


  135. KHAN MS, Memon MM, Amin E, Yamani N, et al
    Use of Balloon Atrial Septostomy in Patients With Advanced Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
    Chest. 2019;156:53-63.
    PubMed     Abstract available


  136. KHAN NA, Khan RA, Tonelli AR, Highland KB, et al
    Pulmonary Edema Following Initiation of Parenteral Prostacyclin Therapy for Pulmonary Arterial Hypertension: A Retrospective Study.
    Chest. 2019;156:45-52.
    PubMed     Abstract available


    June 2019
  137. JALIL BA, Smith JS, El-Kersh K
    A 34-Year-Old Woman With Hoarseness of Voice and an Abnormal Echocardiogram.
    Chest. 2019;155:e163-e166.
    PubMed     Abstract available


    May 2019
  138. GILLMEYER KR, Lee MM, Link AP, Klings ES, et al
    Response.
    Chest. 2019;155:1077-1078.
    PubMed    


  139. CALLAHAN SJ, Papani R
    Pulmonary Arterial Hypertension: Too Complex for Physicians, Too Complex for ICD Diagnosis Codes.
    Chest. 2019;155:1077.
    PubMed    


  140. CHEMLA D, Boulate D, Weatherald J, Lau EMT, et al
    Golden Ratio and the Proportionality Between Pulmonary Pressure Components in Pulmonary Arterial Hypertension.
    Chest. 2019;155:991-998.
    PubMed     Abstract available


    April 2019
  141. ELLIOTT CG
    Real-World Data for Pulmonary Arterial Hypertension.
    Chest. 2019;155:653-654.
    PubMed    


  142. GILLMEYER KR, Lee MM, Link AP, Klings ES, et al
    Accuracy of Algorithms to Identify Pulmonary Arterial Hypertension in Administrative Data: A Systematic Review.
    Chest. 2019;155:680-688.
    PubMed     Abstract available


    March 2019
  143. KLINGER JR, Elliott CG, Levine DJ, Bossone E, et al
    Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report.
    Chest. 2019;155:565-586.
    PubMed     Abstract available


    February 2019
  144. D'ANDREA A, Stanziola AA, Saggar R, Saggar R, et al
    Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis: An Exercise Two-Dimensional Speckle Tracking Doppler Echocardiography Study.
    Chest. 2019;155:297-306.
    PubMed     Abstract available


    January 2019
  145. LEJEALLE C, Paradis V, Bruno O, de Raucourt E, et al
    Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.
    Chest. 2019;155:123-136.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.